肾脏病学预后模型:现状与方向的范围综述
该范围综述检索PubMed和Embase,纳入602项开发、验证或更新CKD患者预后模型的研究,其中30.1%涉及CKD人群、31.6%透析人群、38.4%肾移植人群。最常预测的结局为死亡、肾病进展和移植物存活,但校准报告、外部验证和可用模型版本报告不足。
要点
- 预后模型研究集中在CKD、透析和肾移植人群,主要预测死亡、肾病进展和移植物存活。
- 仅43.4%研究报告校准结果,26.7%模型经外部验证,45.8%开发研究未报告可用模型版本。
- 需加强患者报告结局、方法学严谨性、完整报告、外部验证、更新和影响评估。
核心结论
- 已为CKD患者开发大量预后模型,主要针对肾病进展和患者/移植物存活相关结局。
- 为弥合预测研究与肾脏患者照护之间的差距,亟需关注患者报告结局、方法学严谨性、预后模型完整报告、外部验证、更新和影响评估。
研究设计与样本
- 范围综述,检索PubMed和Embase中开发、验证或更新CKD患者预后模型的研究。
- 共纳入602项研究,其中30.1%涉及CKD人群、31.6%涉及透析人群、38.4%涉及肾移植人群。
主要发现
- 最常预测的结局为死亡(n=129)、肾病进展(n=75)和移植物存活(n=54)。
- 80.4%的研究提供区分度指标,但仅43.4%报告校准结果。
- 415项开发研究中,28.0%未进行任何验证,57.6%仅进行内部验证。
- 仅111个模型(26.7%)在开发研究本身或独立外部验证研究中得到外部验证。
- 45.8%的开发研究未报告可用的模型版本。
临床怎么用
- 临床使用预后模型前应关注其是否报告校准结果和外部验证情况。
- 优先选择报告了可用模型版本且经过外部验证的预后模型辅助个体化决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Prognostic models can strongly support individualized care provision and well-informed shared decision making. There has been an upsurge of prognostic research in the field of nephrology, but the uptake of prognostic models in clinical practice remains limited. Therefore, we map out the research field of prognostic models for kidney patients and provide directions on how to proceed from here. We performed a scoping review of studies developing, validating, or updating a prognostic model for patients with CKD. We searched all published models in PubMed and Embase and report predicted outcomes, methodological quality, and validation and/or updating efforts. We found 602 studies, of which 30.1% concerned CKD populations, 31.6% dialysis populations, and 38.4% kidney transplantation populations. The most frequently predicted outcomes were mortality ( n =129), kidney disease progression ( n =75), and kidney graft survival ( n =54). Most studies provided discrimination measures (80.4%), but much less showed calibration results (43.4%). Of the 415 development studies, 28.0% did not perform any validation and 57.6% performed only internal validation. Moreover, only 111 models (26.7%) were externally validated either in the development study itself or in an independent external validation study. Finally, in 45.8% of development studies no useable version of the model was reported. To conclude, many prognostic models have been developed for patients with CKD, mainly for outcomes related to kidney disease progression and patient/graft survival. To bridge the gap between prediction research and kidney patient care, patient-reported outcomes, methodological rigor, complete reporting of prognostic models, external validation, updating, and impact assessment urgently need more attention.
引用
- Milders J, Ramspek CL, Janse RJ, et al. Prognostic Models in Nephrology: Where Do We Stand and Where Do We Go from Here? Mapping Out the Evidence in a Scoping Review. J Am Soc Nephrol. 2023. PMID: 38082484. doi:10.1681/ASN.0000000000000285
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。